Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review
Authors (first, second and last of 7)
Volume 11, issue 1, December 2018
143 articles in this issue
-
-
Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing
Authors (first, second and last of 4)
-
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Authors (first, second and last of 29)
-
-
The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer
Authors (first, second and last of 8)
-
Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective
Authors (first, second and last of 9)
-
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways
Authors (first, second and last of 12)
-
Proton beam therapy for cancer in the era of precision medicine
Authors (first, second and last of 5)
-
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD
Authors (first, second and last of 16)
-
-
-
-
Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies
Authors (first, second and last of 4)
-
-
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
Authors (first, second and last of 23)
-
Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma
Authors (first, second and last of 15)
-
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC
Authors (first, second and last of 18)
-
-
-
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
Authors (first, second and last of 15)
-
Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis
Authors (first, second and last of 15)
-
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
Authors (first, second and last of 12)
-
-
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
Authors (first, second and last of 9)
-
JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells
Authors (first, second and last of 5)
-
Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications
Authors (first, second and last of 8)
-
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
Authors (first, second and last of 13)
-
-
Overexpression of CLC-3 is regulated by XRCC5 and is a poor prognostic biomarker for gastric cancer
Authors (first, second and last of 8)
-
Selective killing of circulating tumor cells prevents metastasis and extends survival
Authors (first, second and last of 4)
-
The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5
Authors (first, second and last of 11)
-
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
Authors (first, second and last of 9)
-
-
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
Authors (first, second and last of 19)
-
Mouse avatar models of esophageal squamous cell carcinoma proved the potential for EGFR-TKI afatinib and uncovered Src family kinases involved in acquired resistance
Authors (first, second and last of 10)
-
The CCR4-NOT complex is a tumor suppressor in Drosophila melanogaster eye cancer models
Authors (first, second and last of 10)
-
-
-
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL
Authors (first, second and last of 4)
-
Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
Authors (first, second and last of 6)
-
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag
Authors (first, second and last of 12)
-
Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy
Authors (first, second and last of 13)
-
Evaluation of an alternative ruxolitinib dosing regimen in patients with myelofibrosis: an open-label phase 2 study
Authors (first, second and last of 5)
-
-
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
Authors (first, second and last of 24)
-
-
-
Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
Authors (first, second and last of 33)
-
Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy
Authors (first, second and last of 12)
-
Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
Authors (first, second and last of 21)
